ECMC Impact Report 2017

Since 2007, the Experimental Cancer Medicine Centres (ECMC) initiative has played a pivotal role in driving the development of experimental agents that will become the cancer treatments of tomorrow. 

The initiative is jointly funded by Cancer Research UK and the health departments for England, Scotland, Wales and Northern Ireland.

From research nurses to data managers; trial coordinators to pharmacists, we invest in expertise and infrastruture needed to deliver early phase cancer trials in the UK.

Read and download the ECMC Impact Report here.